MariMed Earnings

Acquisitions & Expansion Boost Marimed's Q4 Revenue 6% Sequentially, 2022 Sales Increased To $134M

MariMed, Inc. (OTCQX: MRMD) announced its financial results Wednesday afternoon for the fourth quarter and full year ended December 31, 2022. The company reported sales for the year increased to $134 million, compared with $121.5 million the prior year.

MariMed Shares Surge On Increased Revenue Guidance To $118M, Sixth Sequential Quarter Of Positive EBITDA Growth

The multi-state cannabis operator MariMed, Inc. (OTCQX: MRMD) announced its second-quarter financial and operating results Monday with revenue of $32.6 million, up by 215% from the same period of 2020.